77 related articles for article (PubMed ID: 22196509)
1. Significant neurological improvement in two patients with amyotrophic lateral sclerosis after 4 weeks of treatment with acupuncture injection point therapy using enercel.
Liang S; Christner D; Du Laux S; Laurent D
J Acupunct Meridian Stud; 2011 Dec; 4(4):257-61. PubMed ID: 22196509
[TBL] [Abstract][Full Text] [Related]
2. Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations.
Chen L; Chen D; Xi H; Wang Q; Liu Y; Zhang F; Wang H; Ren Y; Xiao J; Wang Y; Huang H
Cell Transplant; 2012; 21 Suppl 1():S65-77. PubMed ID: 22507682
[TBL] [Abstract][Full Text] [Related]
3. [A 49-year-old man with progressive bulbar palsy and respiratory failure].
Motoi Y; Satoh K; Matsumine H; Wakiya M; Mori H; Shirai T; Kondo T; Mizuno Y
No To Shinkei; 1998 Jan; 50(1):93-100. PubMed ID: 9493205
[TBL] [Abstract][Full Text] [Related]
4. [Comparative observation on electroacupuncture combined with acupoint-injection for treatment of oculomotor paralysis induced by aneurysm of cerebral posterior communicating artery].
Zhang XZ
Zhongguo Zhen Jiu; 2008 Apr; 28(4):248-50. PubMed ID: 18481712
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
6. [Neurological CPC.57. An 80-year-old woman with four years history of muscle atrophy involving lower extremities predominantly on the right side].
Miwa H; Mori H; Sumino S; Matsuoka S; Shirai T; Imai H; Mizuno Y
No To Shinkei; 1997 Sep; 49(9):857-65. PubMed ID: 9311007
[TBL] [Abstract][Full Text] [Related]
7. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
[TBL] [Abstract][Full Text] [Related]
8. Progressive speech deterioration and dysphagia in amyotrophic lateral sclerosis: case report.
Dworkin JP; Hartman DE
Arch Phys Med Rehabil; 1979 Sep; 60(9):423-5. PubMed ID: 496610
[TBL] [Abstract][Full Text] [Related]
9. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).
Yoshino H; Kimura A
Amyotroph Lateral Scler; 2006 Dec; 7(4):241-5. PubMed ID: 17127563
[TBL] [Abstract][Full Text] [Related]
12. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
[TBL] [Abstract][Full Text] [Related]
13. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S
Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065
[TBL] [Abstract][Full Text] [Related]
14. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
15. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
16. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
17. Electroacupuncture reduces neuroinflammatory responses in symptomatic amyotrophic lateral sclerosis model.
Yang EJ; Jiang JH; Lee SM; Hwang HS; Lee MS; Choi SM
J Neuroimmunol; 2010 Jun; 223(1-2):84-91. PubMed ID: 20460191
[TBL] [Abstract][Full Text] [Related]
18. Trial of celecoxib in amyotrophic lateral sclerosis.
Cudkowicz ME; Shefner JM; Schoenfeld DA; Zhang H; Andreasson KI; Rothstein JD; Drachman DB
Ann Neurol; 2006 Jul; 60(1):22-31. PubMed ID: 16802291
[TBL] [Abstract][Full Text] [Related]
19. [A 54-year-old man with generalized muscle atrophy and oculomotor paresis].
Komiya T; Shike T; Mori H; Santo ML; Suda K; Kondo T; Mizuno Y
No To Shinkei; 1994 Sep; 46(9):895-904. PubMed ID: 7999450
[TBL] [Abstract][Full Text] [Related]
20. Specific antivenom for Bungarus candidus.
Leeprasert W; Kaojarern S
J Med Assoc Thai; 2007 Jul; 90(7):1467-76. PubMed ID: 17710993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
